PhenoSign


Developer of in‑situ, time‑stamped, multi‑modal body fluid analysis systems. The organization combines microfluidics, photonics, microsensors, bioinformatics and computational models (including AI/ML) to generate real‑time biomarker data for clinical monitoring, early detection and research. Activities include collaborative clinical validation, academic research partnerships and dissemination of technical whitepapers and podcasts.

Industries

biotechnology
health-care
manufacturing

Nr. of Employees

small (1-50)

PhenoSign

Bubikon, Zurich, Switzerland, Europe


Products

System for body liquid analysis

A clinically oriented system concept for in‑situ, time‑stamped, multi‑modal analysis of body fluids intended to provide real‑time biomarker data for monitoring and diagnostic applications.


Services

Research collaborations and clinical partnerships

Collaborative research agreements with academic and clinical partners to co‑develop and validate body fluid diagnostic technologies.

Clinical validation and trial support

Support for designing and executing clinical validation studies in partnership with clinical sites to assess diagnostic performance.

Technical whitepapers and educational media

Distribution of whitepapers, podcasts and informational material on real‑time diagnostics, precision medicine and system design.

Expertise Areas

  • Body fluid diagnostics
  • Point‑of‑care and ICU monitoring
  • Clinical validation and trial collaboration
  • Microfluidics and lab‑on‑a‑chip systems
  • Show More (4)

Key Technologies

  • Microfluidics
  • Lab‑on‑a‑chip
  • Photonics
  • Microsensors
  • Show More (5)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.